Insider trades
Robert Chess, Director of Nektar Therapeutics NKTR, has filed 0 purchases and 11 sales on the open market. Over the past 12 months that comes to a net sale of $575.4K. The latest trade was on 09/23.
Robert Chess
Director
- Company
- Nektar Therapeutics NKTR
- First filing
- 23/02/09
- Trades
- 25 trades
- Buys / sales
- 0 / 11
- 12-month net buying
- −$575.4K
- Last trade
- 09/23
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Twist BioscienceTWST | Open-market sale10b5-1 plan | 03/17 | 03/19 | 10,000 sh | $47.00 | $470,000 | −32.2% |
Twist BioscienceTWST | Open-market sale | 02/13 | 02/18 | 2,184 sh | $48.26 | $105,399.84 | −9.4% |
Twist BioscienceTWST | Open-market sale | 25/02/07 | 25/02/11 | 2,940 sh | $53.14 | $156,231.6 | −13.9% |
Twist BioscienceTWST | Open-market sale10b5-1 plan | 25/01/07 | 25/01/10 | 5,000 sh | $50.00 | $250,000 | −23.1% |
TWST | Open-market sale10b5-1 plan | 24/12/05 | 24/12/30 | 3,504 sh2 trades | $51.85avg. | $181,688.55 | −13.9% |
TWST | Open-market sale10b5-1 plan | 24/11/11 | 24/11/13 | 3,600 sh2 trades | $47.26avg. | $170,146.52 | −14.3% |
| Open-market sale10b5-1 plan | 24/06/14 | 24/06/14 | 19,500 sh | $1.20 | $23,400 | −7.1% | |
Twist BioscienceTWST | Open-market sale | 24/02/08 | 24/02/09 | 4,110 sh | $34.98 | $143,767.8 | −6.0% |
| Open-market sale10b5-1 plan | 22/09/22 | 23/09/20 | 10,200 sh | $0.67 | $6,834 | −3.6% |
